Hemogenyx Pharmaceuticals Plc (HEMO.L) LSE

155.50

-3(-1.89%)

Updated at August 19 08:34AM

Currency In GBp

Valuation

Market Cap13.37M
Enterprise Value15.83M
P/E Ratio-1.98
PEG Ratio-1.6
Price/Sales Ratio0
Price/Book Ratio6.19
Enterprise/Revenue0
Enterprise/EBITDA-1.41

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.67
Return On Equity-1.42

Income Statement

Revenue0
Revenue/Share0
Gross Profit-639,285
EBITDA-4.71M
Net Income-5.62M
Diluted EPS-1.7

Balance Sheet

Total Cash159,265
Total Cash/Share0.05
Total Debt2.62M
Total Debt/Equity2.92
Current Ratio0.72
Book Value Per Share0.24

Price History

52-Week Change-71.29
52-Week High1,200
52-Week Low124
Moving Average 50 Days156.13
Moving Average 200 Days263.46

Statistics

Average Volume35,675
Shares Outstanding4.73M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:400
Last Split DateDecember 13, 2024